Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...
Las acciones de Masimo Corp. (NASDAQ:MASI) recibieron el miércoles una mejora en su calificación por parte de Raymond James, pasando de "Market Perform" a "Outperform". La firma ha establecido ...
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
para las acciones de Masimo Corp. (NASDAQ:MASI) y aumentó el precio objetivo de 165 a 180 dólares. Este ajuste se produce tras el anuncio de Masimo de unos ingresos del tercer trimestre de 505 ...
Masimo Corp. ( (MASI) ) has released its Q3 earnings. Here is a breakdown of the information Masimo Corp. presented to its investors. Masimo ...
Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...
Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...
Revenue: US$504.6m (up 5.4% from 3Q 2023). Net income: US$9.80m (down 7.5% from 3Q 2023). Profit margin: 1.9% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS ...
In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is ... The company is de-emphasizing two products focused on opioid management, Chief Operating ...
El miércoles, las acciones de Masimo Corp. (NASDAQ:MASI) recibieron una mejora por parte de Raymond James, pasando de la calificación "Market Perform" a "Outperform". La firma ha fijado un precio ...
Masimo sells a range of devices used for patient monitoring that feature a proprietary pulse oximetry technology called Signal Extraction Technology (SET). In the latest update on that patent spat ...
Masimo Corporation (MASI), una empresa global de tecnología médica, celebró su conferencia telefónica sobre los resultados del tercer trimestre de 2024 el [fecha], en la que informó de un aumento ...